Roman GLP-1 (Ro): What the Platform Offers, Pricing & How It Compares

Getting a GLP-1 prescription online changed in 2025.

Key Takeaways

• What Ro offers: Online consultations, prescriptions for semaglutide (compounded and branded) and tirzepatide, delivered to your door or sent to a local pharmacy.
• Pricing model: Subscription-based; typically includes provider visits, messaging support, and medication — pricing varies by drug type and dose.
• Key risk: Compounded semaglutide access became legally constrained after 2025 FDA rulings; Ro's business model depends partly on how this evolves.
• Who it suits: People who want a lower-friction path to a GLP-1 prescription and ongoing support without navigating traditional insurance and specialist waitlists.
• Comparison position: Ro is legitimate and well-resourced but not meaningfully differentiated from Hims & Hers or Found on the core product.
• Honest verdict: For branded medications, Ro is a good facilitator. For compounded semaglutide, read the current landscape carefully before committing.

Ro (formerly Roman) built one of the earlier telehealth brands around men's health, then expanded aggressively into GLP-1 prescribing when semaglutide demand exploded. The platform is real, the prescriptions are legitimate, and the clinical model works. The more complicated question in 2026 is about the compounded semaglutide product specifically — and what the ongoing FDA regulatory picture means for your subscription continuity.

What the Ro Platform Actually Provides

Ro is a telehealth company, not a pharmacy.

The distinction matters. When you sign up for Ro's weight loss program, you're paying for: an asynchronous or video consultation with a licensed provider (typically a nurse practitioner or physician), an ongoing clinical relationship for dose adjustments and check-ins, and medication either shipped directly or sent to a local pharmacy of your choice. The provider is licensed in your state, the prescriptions are real prescriptions, and the clinical oversight is genuine — it's not a rubber-stamp operation.

The intake process is online: you complete a health questionnaire covering weight history, current medications, medical conditions, and weight loss goals. A provider reviews it and either approves a prescription, requests a video visit, or declines if you're not a good candidate. Most straightforward cases are handled asynchronously within 24–48 hours.

Ro offers both branded GLP-1 medications (Wegovy, Ozempic, Zepbound, Mounjaro) if you have insurance coverage or are paying cash for the branded product, and compounded semaglutide and tirzepatide through affiliated compounding pharmacies for patients seeking lower-cost alternatives.

Pricing: What You're Actually Paying For

Ro's pricing has shifted multiple times, and the current structure depends on what medication you're getting.

For compounded semaglutide programs, pricing has typically started in the $200–$350 per month range, which includes the medication and provider access. This is substantially below the $900–$1,100 list price of branded Wegovy, which is why compounded options became popular. For branded medications, Ro functions more as a prescribing facilitator — you'd still need to work out insurance coverage or pay list price.

The subscription usually covers unlimited provider messaging and scheduled check-ins, dose adjustments, and access to educational content. What it doesn't include in most cases: lab work (you'd order that through your primary care provider or a separate lab service), and any out-of-pocket costs if you're filling at a retail pharmacy rather than through Ro's dispensing partners.

Watch for auto-renewal terms. Ro, like most subscription telehealth platforms, defaults to automatic monthly or quarterly renewal. If your weight loss stalls, you want to pause rather than cancel, or the FDA's rules on compounding affect what you're getting, the cancellation process and any associated fees are worth understanding upfront before you commit.

The Compounded Semaglutide Situation (Read This Carefully)

This is the part of the Ro conversation that matters most in 2026.

Compounded medications are prepared by licensed compounding pharmacies and have a different regulatory status than FDA-approved branded drugs. When Wegovy and Ozempic were on the FDA's drug shortage list, compounding pharmacies were legally permitted to prepare semaglutide in bulk — which is how platforms like Ro, Hims & Hers, and dozens of others were able to offer low-cost semaglutide alternatives at scale.

In 2025, the FDA determined that semaglutide was no longer in shortage, which triggered restrictions on compounding. The legal picture became complex: the FDA moved against bulk compounding of semaglutide; telehealth platforms pushed back; courts issued mixed rulings; and the regulatory situation remained in flux through 2025 and into 2026. The practical effect: what you can actually get through Ro's compounded program depends on where things stand legally at the time you're reading this.

Ro has navigated this by also offering branded medication access and, in some cases, transitioning patients to branded products. But if you're considering Ro specifically because compounded semaglutide is more affordable, you should verify what the current availability and legal status are before signing up.

How Ro Compares to Competitors

There are now at least a dozen telehealth platforms prescribing GLP-1 drugs.

Ro's differentiation from Hims & Hers is largely reputational rather than clinical — both offer similar products at similar price points through similar clinical models. If you've had a good experience with Ro's platform for other conditions, that familiarity has real value. If you're starting fresh, both are defensible choices — but understand you're picking between platforms that are more similar than their marketing suggests.

Who Ro Is Best For

Ro works best for a specific type of person in a specific situation.

If you have insurance that covers Wegovy or Zepbound, Ro adds limited value — you'd work with your prescriber and fill at a retail pharmacy. If you're uninsured or your plan excludes obesity drugs, Ro's compounded semaglutide option (when legally available) offers a meaningfully cheaper path. If you're in a rural area with limited access to an obesity medicine specialist, Ro's nationwide telehealth reach solves a real access problem.

Where Ro adds less value: if you have a complex medical history that needs in-person evaluation, if you're on medications with significant drug interactions that require careful management, or if you want labs, imaging, or metabolic panel tracking built into your program. Calibrate includes labs; Ro does not, by default.

The Honest Assessment

Ro is a legitimate, functional telehealth platform.

The providers are real. The prescriptions are valid. The clinical oversight is more than a formality. For people who want a frictionless path to a GLP-1 prescription without navigating specialist waitlists or fighting with insurance, Ro delivers. The concern isn't about Ro's legitimacy — it's about whether the lower-cost compounded semaglutide product that made the platform appealing will remain stable as the regulatory environment continues to shift.

If you're considering Ro in 2026, verify two things before subscribing: what medication you'd actually receive (compounded vs. branded), and what the cancellation terms look like if the product changes. With that information, you can make a clear-eyed decision.

Frequently Asked Questions

Is Ro (Roman) a legitimate medical provider?
Yes. Ro is a licensed telehealth platform that connects patients with licensed healthcare providers in their state. Prescriptions issued through Ro are valid prescriptions, and the providers are real clinicians. The platform is not a workaround — it operates within the same legal framework as any telehealth provider.

Can I get Wegovy through Ro?
Yes, Ro can facilitate a Wegovy prescription if you're clinically appropriate. For branded Wegovy, you'd work with Ro's provider and fill the prescription at a pharmacy — coverage and cost depend on your insurance. Ro also has programs for compounded semaglutide as a lower-cost alternative, subject to current regulatory availability.

What's the difference between compounded and branded semaglutide?
Branded semaglutide (Ozempic, Wegovy) is manufactured by Novo Nordisk to FDA-approved specifications. Compounded semaglutide is prepared by a licensed compounding pharmacy from active pharmaceutical ingredients. The molecule can be the same, but the manufacturing standards, quality controls, and regulatory oversight differ. Compounded semaglutide is legally permitted under specific conditions but does not carry FDA approval of the final product.

How does Ro compare to Hims & Hers for GLP-1 prescriptions?
Both platforms offer similar products — compounded and branded semaglutide, tirzepatide — through similar asynchronous telehealth models at comparable price points. The main differences are in platform experience, subscription terms, and any included support services. Neither has a meaningful clinical advantage over the other on the GLP-1 prescribing itself.

Does Ro include lab work in their GLP-1 program?
Standard Ro subscriptions typically do not include lab work. You'd generally need to order labs separately through your primary care provider or a direct-to-consumer lab service. Platforms like Calibrate include labs as part of their more structured programs, which is a meaningful difference if baseline metabolic testing matters to you.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment.